![Molecules | Free Full-Text | Transcription Factors as Therapeutic Targets in Chronic Kidney Disease | HTML Molecules | Free Full-Text | Transcription Factors as Therapeutic Targets in Chronic Kidney Disease | HTML](https://www.mdpi.com/molecules/molecules-23-01123/article_deploy/html/images/molecules-23-01123-g001-550.jpg)
Molecules | Free Full-Text | Transcription Factors as Therapeutic Targets in Chronic Kidney Disease | HTML
![Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl - Journal of Cardiac Failure Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl - Journal of Cardiac Failure](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/82802f72-5a31-4616-b8d0-2ee9e94e0b69/gr1.jpg)
Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl - Journal of Cardiac Failure
![Cancers | Free Full-Text | Targeting Crosstalk between Nrf-2, NF-κB and Androgen Receptor Signaling in Prostate Cancer | HTML Cancers | Free Full-Text | Targeting Crosstalk between Nrf-2, NF-κB and Androgen Receptor Signaling in Prostate Cancer | HTML](https://www.mdpi.com/cancers/cancers-10-00352/article_deploy/html/images/cancers-10-00352-g001.png)
Cancers | Free Full-Text | Targeting Crosstalk between Nrf-2, NF-κB and Androgen Receptor Signaling in Prostate Cancer | HTML
![Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease | Signal Transduction and Targeted Therapy Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease | Signal Transduction and Targeted Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41392-021-00628-x/MediaObjects/41392_2021_628_Fig1_HTML.png)
Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease | Signal Transduction and Targeted Therapy
![Frontiers | Contribution of Nrf2 Modulation to the Mechanism of Action of Analgesic and Anti-inflammatory Drugs in Pre-clinical and Clinical Stages Frontiers | Contribution of Nrf2 Modulation to the Mechanism of Action of Analgesic and Anti-inflammatory Drugs in Pre-clinical and Clinical Stages](https://www.frontiersin.org/files/Articles/420947/fphar-09-01536-HTML/image_m/fphar-09-01536-g002.jpg)
Frontiers | Contribution of Nrf2 Modulation to the Mechanism of Action of Analgesic and Anti-inflammatory Drugs in Pre-clinical and Clinical Stages
![Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure | Journal of Pharmacology and Experimental Therapeutics Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/371/3/642/F2.large.jpg)
Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure | Journal of Pharmacology and Experimental Therapeutics
![Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease - ScienceDirect Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0085253819305034-fx1.jpg)
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease - ScienceDirect
![Bardoxolone Methyl and a Related Triterpenoid Downregulate cMyc Expression in Leukemia Cells | Molecular Pharmacology Bardoxolone Methyl and a Related Triterpenoid Downregulate cMyc Expression in Leukemia Cells | Molecular Pharmacology](https://molpharm.aspetjournals.org/sites/default/files/highwire/molpharm/91/5.cover-source.jpg)
Bardoxolone Methyl and a Related Triterpenoid Downregulate cMyc Expression in Leukemia Cells | Molecular Pharmacology
![Antioxidants | Free Full-Text | Pharmacotherapy against Oxidative Stress in Chronic Kidney Disease: Promising Small Molecule Natural Products Targeting Nrf2-HO-1 Signaling | HTML Antioxidants | Free Full-Text | Pharmacotherapy against Oxidative Stress in Chronic Kidney Disease: Promising Small Molecule Natural Products Targeting Nrf2-HO-1 Signaling | HTML](https://www.mdpi.com/antioxidants/antioxidants-10-00258/article_deploy/html/images/antioxidants-10-00258-g001.png)
Antioxidants | Free Full-Text | Pharmacotherapy against Oxidative Stress in Chronic Kidney Disease: Promising Small Molecule Natural Products Targeting Nrf2-HO-1 Signaling | HTML
![Bardoxolone Methyl Decreases Megalin and Activates Nrf2 in the Kidney | American Society of Nephrology Bardoxolone Methyl Decreases Megalin and Activates Nrf2 in the Kidney | American Society of Nephrology](https://jasn.asnjournals.org/content/jnephrol/23/10/1663/F4.large.jpg)